Q2 2026 Holdings
Filed 2026-08-14 | 68 holdings | $4.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| BioMarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $344.8M | 6,025,000 | 8.1% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $316.8M | 1,880,000 | 7.4% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $313.1M | 2,349,443 | 7.3% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $235.7M | 435,000 | 5.5% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $203.0M | 4,000,000 | 4.7% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $195.3M | 8,050,000 | 4.6% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $155.9M | 5,250,000 | 3.6% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $132.2M | 19,415,000 | 3.1% |
| Arrowhead Pharmaceuticals Inc(ARWR) | COM | 04280A100 | $128.4M | 1,575,000 | 3.0% |
| Abbott Laboratories(ABT) | COM | 002824100 | $127.0M | 1,400,000 | 3.0% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $120.5M | 1,400,000 | 2.8% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $113.4M | 1,550,000 | 2.6% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $111.3M | 4,600,000 | 2.6% |
| Insulet Corp(PODD) | COM | 45784P101 | $102.0M | 670,000 | 2.4% |
| Ascendis Pharma A/S(ASND) | ORD SHS | K08588103 | $100.0M | 375,000 | 2.3% |
| AstraZeneca PLC(AZN) | ORD | G0593M107 | $85.3M | 450,000 | 2.0% |
| Sanofi SA(SNY) | SPONSORED ADR | 80105N105 | $85.3M | 2,000,000 | 2.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $84.3M | 450,000 | 2.0% |
| BioCryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $83.0M | 8,300,000 | 1.9% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $75.0M | 3,375,000 | 1.8% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $69.8M | 1,000,000 | 1.6% |
| Globus Medical Inc(GMED) | CL A | 379577208 | $67.2M | 850,000 | 1.6% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $66.1M | 1,050,000 | 1.5% |
| Immatics NV(IMTX) | SHS | N44445109 | $62.6M | 6,175,000 | 1.5% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $57.8M | 3,100,000 | 1.4% |
| Immunocore Holdings PLC(IMCR) | ADS | 45258D105 | $57.2M | 1,800,000 | 1.3% |
| Repligen Corp(RGEN) | COM | 759916109 | $54.6M | 400,000 | 1.3% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $46.1M | 800,000 | 1.1% |
| uniQure NV(QURE) | SHS | N90064101 | $43.1M | 935,000 | 1.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $42.3M | 700,000 | 1.0% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $38.3M | 545,000 | 0.9% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $34.9M | 65,000 | 0.8% |
| Alcon AG(ALC) | ORD SHS | H01301128 | $33.6M | 500,000 | 0.8% |
| Myriad Genetics Inc(MYGN) | COM | 62855J104 | $32.7M | 5,735,000 | 0.8% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $30.4M | 730,000 | 0.7% |
| Crescent Biopharma Inc(CBIO) | COM | G2545C104 | $29.3M | 1,630,000 | 0.7% |
| GE HealthCare Technologies Inc(GEHC) | COMMON STOCK | 36266G107 | $28.8M | 450,000 | 0.7% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $26.7M | 250,000 | 0.6% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $26.5M | 680,000 | 0.6% |
| Beta Bionics Inc(BBNX) | COM | 08659B102 | $25.1M | 1,600,000 | 0.6% |
| Regeneron Pharmaceuticals Inc(REGN) | COM | 75886F107 | $24.9M | 40,000 | 0.6% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $21.6M | 2,160,000 | 0.5% |
| Alto Neuroscience Inc(ANRO) | COM SHS | 02157Q109 | $20.7M | 785,000 | 0.5% |
| First Tracks Biotherapeutics I(TRAX) | ORD SHS | 337185102 | $20.4M | 1,013,000 | 0.5% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $20.1M | 4,320,000 | 0.5% |
| Savara Inc(SVRA) | COM | 805111101 | $16.8M | 2,720,000 | 0.4% |
| Damora Therapeutics Inc(GLTO) | COM NEW | 36322Q206 | $15.0M | 575,000 | 0.3% |
| SpyGlass Pharma Inc(SGP) | COM SHS | 85220G109 | $14.9M | 670,000 | 0.3% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $14.6M | 425,000 | 0.3% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $14.3M | 775,000 | 0.3% |